Detailansicht

Vraka, C., Murgaš, M., Rischka, L., Geist, B. K., Lanzenberger, R., Gryglewski, G., Zenz, T., Wadsak, W., Mitterhauser, M., Hacker, M., Philippe, C., & Pichler, V. (2022). Simultaneous radiomethylation of [¹¹C]harmine and [¹¹C]DASB and kinetic modeling approach for serotonergic brain imaging in the same individual. Scientific Reports, 12(1), [3283]. https://doi.org/10.1038/s41598-022-06906-0

Balber, T., Tran, L., Bencurova, K., Raitanen, J., Egger, G., & Mitterhauser, M. (2022). Experimental Nuclear Medicine Meets Tumor Biology. Pharmaceuticals, 15(2), [227]. https://doi.org/10.3390/ph15020227

Calabretta, R., Staber, P. B., Kornauth, C., Lu, X., Binder, P., Pichler, V., Mitterhauser, M., Haug, A., Li, X., & Hacker, M. (2021). Immune Checkpoint Inhibitor Therapy Induces Inflammatory Activity in the Large Arteries of Lymphoma Patients under 50 Years of Age. Biology, 10(11), [1206]. https://doi.org/10.3390/biology10111206

Rischka, L., Vraka, C., Pichler, V., Rasul, S., Nics, L., Gryglewski, G., Handschuh, P., Murgas, M., Godbersen, G. M., Silberbauer, L. R., Unterholzner, J., Wotawa, C., Haider, A., Ahmed, H., Schibli, R., Mindt, T., Mitterhauser, M., Wadsak, W., Hahn, A., ... Ametamey, S. M. (2021). First-in-human mapping of the GluN2B subunits of the N-methyl-D-aspartate receptor using (R)-[(11)Cc]Me-NB1 and PET. European Journal of Nuclear Medicine and Molecular Imaging, 48(SUPPL 1), 296.

Philippe, C., Klebermass, E-M., Balber, T., Kulterer, O. C., Zeilinger, M., Egger, G., Dumanic, M., Herz, C. T., Kiefer, F. W., Scheuba, C., Scherer, T., Fuernsinn, C., Vraka, C., Pallitsch, K., Spreitzer, H., Wadsak, W., Viernstein, H., Hacker, M., & Mitterhauser, M. (2021). Discovery of melanin-concentrating hormone receptor 1 in brown adipose tissue. Annals of the New York Academy of Sciences, 1494(1), 70-86. https://doi.org/10.1111/nyas.14563

Hana, C. A., Klebermass, E. M., Balber, T., Mitterhauser, M., Quint, R., Hirtl, Y., Klimpke, A., Somloi, S., Hutz, J., Sperr, E., Eder, P., Jašprová, J., Valášková, P., Vítek, L., Heiss, E., & Wagner, K. H. (2021). Inhibition of Lipid Accumulation in Skeletal Muscle and Liver Cells: A Protective Mechanism of Bilirubin Against Diabetes Mellitus Type 2. Frontiers in Pharmacology, 11, [636533]. https://doi.org/10.3389/fphar.2020.636533

Sauerzopf, U., Weidenauer, A., Dajic, I., Bauer, M., Bartova, L., Meyer, B., Nics, L., Philippe, C., Pfaff, S., Pichler, V., Mitterhauser, M., Wadsak, W., Hacker, M., Kasper, S., Lanzenberger, R., Pezawas, L., Praschak-Rieder, N., & Willeit, M. (2021). Disrupted relationship between blood glucose and brain dopamine D2/3 receptor binding in patients with first-episode schizophrenia. NeuroImage: Clinical, 32, [102813]. https://doi.org/10.1016/j.nicl.2021.102813

Klebermass, E-M., Mahmudi, M., Geist, B. K., Pichler, V., Vraka, C., Balber, T., Miller, A., Haschemi, A., Viernstein, H., Rohr-Udilova, N., Hacker, M., & Mitterhauser, M. (2021). If It Works, Don’t Touch It? A Cell-Based Approach to Studying 2-[18F]FDG Metabolism. Pharmaceuticals, 14(9), [910]. https://doi.org/10.3390/ph14090910

Rasul, S., Hartenbach, M., Wollenweber, T., Kretschmer-Chott, E., Grubmüller, B., Kramer, G., Shariat, S., Wadsak, W., Mitterhauser, M., Pichler, V., Vraka, C., Hacker, M., & Haug, A. R. (2021). Prediction of response and survival after standardized treatment with 7400 MBq ¹⁷⁷Lu-PSMA-617 every 4 weeks in patients with metastatic castration-resistant prostate cancer. European Journal of Nuclear Medicine and Molecular Imaging, 48, 1650–1657. https://doi.org/10.1007/s00259-020-05082-5

Calabretta, R., Hoeller, C., Pichler, V., Mitterhauser, M., Karanikas, G., Haug, A., Li, X., & Hacker, M. (2020). Immune Checkpoint Inhibitor Therapy Induces Inflammatory Activity in Large Arteries. Circulation, 142(24), 2396–2398. https://doi.org/10.1161/CIRCULATIONAHA.120.048708

Klebermass, E-M., Mahmudi, M., Miller, A., Pichler, V., Vraka, C., Balber, T., Haschemi, A., Wadsak, W., Hacker, M., Viernstein, H., & Mitterhauser, M. (2020). 2-[F-18]FDG metabolism: The role of alternative metabolic pathways. European Journal of Nuclear Medicine and Molecular Imaging, 47(Suppl 1), S12-S13. [OP-022]. https://doi.org/10.1007/s00259-020-04988-4

Baldinger-Melich, P., Gryglewski, G., Philippe, C., Murgaš, M., James, G. M., Vraka, C., Silberbauer, L., Balber, T., Vanicek, T., Pichler, V., Unterholzner, J., Kranz, G. S., Hahn, A., Winkler, D., Mitterhauser, M., Wadsak, W., Hacker, M., Kasper, S., Frey, R., & Lanzenberger, R. (2020). Corrigendum to "The effect of electroconvulsive therapy on cerebral monoamine oxidase a expression in treatment-resistant depression investigated using positron emission tomography" [Brain Stimul 12 (3) (2019) 714-723]. Brain Stimulation, 13(5), 1280-1281. https://doi.org/10.1016/j.brs.2020.06.009

Unterholzner, J., Gryglewski, G., Philippe, C., Seiger, R., Pichler, V., Godbersen, G. M., Berroterán-Infante, N., Murgaš, M., Hahn, A., Wadsak, W., Mitterhauser, M., Kasper, S., & Lanzenberger, R. (2020). Topologically Guided Prioritization of Candidate Gene Transcripts Coexpressed with the 5-HT_1A Receptor by Combining in Vivo PET and Allen Human Brain Atlas Data. Cerebral Cortex, 30(6), 3771-3780. https://doi.org/10.1093/cercor/bhz341

Rasul, S., Geist, B. K., Brath, H., Baltzer, P., Sundar, L. K. S., Pichler, V., Mitterhauser, M., Kautzky-Willer, A., & Hacker, M. (2020). Response evaluation of SGLT2 inhibitor therapy in patients with type 2 diabetes mellitus using 18F-FDG PET/MRI. BMJ open diabetes research & care, 8(1). https://doi.org/10.1136/bmjdrc-2019-001135

Weidenauer, A., Bauer, M., Sauerzopf, U., Bartova, L., Nics, L., Pfaff, S., Philippe, C., Berroterán-Infante, N., Pichler, V., Meyer, B. M., Rabl, U., Sezen, P., Cumming, P., Stimpfl, T., Sitte, H. H., Lanzenberger, R., Mossaheb, N., Zimprich, A., Rusjan, P., ... Willeit, M. (2020). On the relationship of first-episode psychosis to the amphetamine-sensitized state: a dopamine D2/3 receptor agonist radioligand study. Translational Psychiatry, 10(1), [2]. https://doi.org/10.1038/s41398-019-0681-5

Silberbauer, L. R., Gryglewski, G., Berroterán-Infante, N., Rischka, L., Vanicek, T., Pichler, V., Hienert, M., Kautzky, A., Philippe, C., Godbersen, G. M., Vraka, C., James, G. M., Wadsak, W., Mitterhauser, M., Hacker, M., Kasper, S., Hahn, A., & Lanzenberger, R. (2019). Serotonin transporter binding in the human brain after pharmacological challenge measured using PET and PET/MR. Frontiers in molecular neuroscience, 12, [172]. https://doi.org/10.3389/fnmol.2019.00172

Gryglewski, G., Klöbl, M., Berroterán-Infante, N., Rischka, L., Balber, T., Vanicek, T., Pichler, V., Kautzky, A., Klebermass, E-M., Reed, M. B., Vraka, C., Hienert, M., James, G. M., Silberbauer, L., Godbersen, G. M., Unterholzner, J., Michenthaler, P., Hartenbach, M., Winkler-Pjrek, E., ... Lanzenberger, R. (2019). Modeling the acute pharmacological response to selective serotonin reuptake inhibitors in human brain using simultaneous PET/MR imaging. European Neuropsychopharmacology, 29(6), 711-719. https://doi.org/10.1016/j.euroneuro.2019.04.001

Vraka, C., Pichler, V., Pfaff, S., Balber, T., Hacker, M., Mitterhauser, M., Wadsak, W., & Philippe, C. (2019). Technical Aspect of the Automated Synthesis and Real-Time Kinetic Evaluation of [11C]SNAP-7941. Journal of Visualized Experiments, (146). https://doi.org/10.3791/59557

Nakuz, T. S., Millinger, F. P., El-Rabadi, K., Weber, M., Pichler, V., Wadsak, W., Mitterhauser, M., Haug, A., Hacker, M., Karanikas, G., Pietschmann, P., & Agis, H. (2019). Characterization of Bone Lesions in Myeloma Before and During Anticancer Therapy Using 18F-FDG-PET/CT and 18F-NaF-PET/CT. Anticancer Research, 39(4), 1943-1952. https://doi.org/10.21873/anticanres.13304

Philippe, C., Zeilinger, M., Dumanic, M., Pichler, F., Fetty, L., Vraka, C., Balber, T., Wadsak, W., Pallitsch, K., Spreitzer, H., Lanzenberger, R., Hacker, M., & Mitterhauser, M. (2019). SNAPshots of the MCHR1: a Comparison Between the PET-Tracers [F-18]FE@SNAP and [C-11]SNAP-7941. Molecular Imaging and Biology, 21(2), 257-268. https://doi.org/10.1007/s11307-018-1212-0